- 全部删除
您的购物车当前为空
VEGFR-2/AURKA-IN-1 (compound 5e) 是一种噻唑烷-4-酮衍生物,表现出抗胶质瘤活性 (IC50: 6.43 μM,LN229)。作为潜在配体,VEGFR-2/AURKA-IN-1 对 AURKA 和 VEGFR-2 具有亲和力。该化合物能引起 DNA 链断裂,表现出细胞毒性和抗癌潜力。
VEGFR-2/AURKA-IN-1 (compound 5e) 是一种噻唑烷-4-酮衍生物,表现出抗胶质瘤活性 (IC50: 6.43 μM,LN229)。作为潜在配体,VEGFR-2/AURKA-IN-1 对 AURKA 和 VEGFR-2 具有亲和力。该化合物能引起 DNA 链断裂,表现出细胞毒性和抗癌潜力。

VEGFR-2/AURKA-IN-1 相关产品
| 产品描述 | VEGFR-2/AURKA-IN-1 (compound 5e) is a thiazolidin-4-one derivative with antitumor activity against glioma (IC50: 6.43 μM in LN229 cells). This compound exhibits affinity for AURKA and VEGFR-2, acting as a potential ligand. VEGFR-2/AURKA-IN-1 induces DNA strand breaks, showcasing cytotoxicity and anticancer potential. |
| 分子式 | C20H15ClF6N2O4S |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容